DYSPORT THERAPEUTIC Canadian Trademark Information

On Friday, July 29, 2016, a canadian trademark registration was filed for DYSPORT THERAPEUTIC by IPSEN BIOPHARM LIMITED *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1793786. The current status of this trademark filing is Registration published. The DYSPORT THERAPEUTIC trademark is filed in the description of Pharmaceutical preparations for the treatment of muscular disorders, namely motor disorders, muscular atrophy, muscular dystrophy, dystonias, muscular dystonia, cervical dystonia, spasticity of the lower limbs, muscular spasm, blepharospasm, spasmodic torticollis, hemifacial spasm, muscle cramp, dynamic equinus foot deformity; pharmaceutical preparations for the treatment of orthopaedic disorders, namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis; pharmaceutical preparations for use in the treatment of neurological diseases, namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the , Pharmaceutical preparations for the treatment of muscular disorders, namely motor disorders, muscular atrophy, muscular dystrophy, dystonias, muscular dystonia, cervical dystonia, spasticity of the lower limbs, muscular spasm, blepharospasm, spasmodic torticollis, hemifacial spasm, muscle cramp, dynamic equinus foot deformity; pharmaceutical preparations for the treatment of orthopaedic disorders, namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis; pharmaceutical preparations for use in the treatment of neurological diseases, namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the treatment of cerebral palsy, spasticity; pharmaceutical preparations for use in the treatment of age-related disorders, namely senile dementia, emphysema, Alzheimer's, and age-related macular degeneration; anti-ageing agents; pharmaceutical preparations for the treatment of ophthalmological disorders, namely retinal disorders, retinal deficit, visual impairment; pharmaceutical preparations for the treatment of pain, namely migraine, myofascial pain, back pain, cancer pain and headache pain; pharmaceutical preparations for the treatment of hyperhidrosis; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex, namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia. , Pharmaceutical preparations for the treatment of muscular disorders, namely motor disorders, muscular atrophy, muscular dystrophy, dystonias, muscular dystonia, cervical dystonia, spasticity of the lower limbs, muscular spasm, blepharospasm, spasmodic torticollis, hemifacial spasm, muscle cramp, dynamic equinus foot deformity; pharmaceutical preparations for use in the treatment of neurological diseases, namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the treatment of cerebral palsy, spasticity; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex, namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia. , Pharmaceutical preparations for the treatment of muscular disorders, namely motor disorders, muscular atrophy, muscular dystrophy, dystonias, muscular dystonia, cervical dystonia, spasticity of the lower limbs, muscular spasm, blepharospasm, spasmodic torticollis, hemifacial spasm, muscle cramp, dynamic equinus foot deformity; pharmaceutical preparations for use in the treatment of neurological diseases, namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the treatment of cerebral palsy, spasticity; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex, namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia. .